H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 4.22 CNY 2.93% Market Closed
Market Cap: 20.8B CNY
Have any thoughts about
Hubei Biocause Pharmaceutical Co Ltd?
Write Note

Net Margin
Hubei Biocause Pharmaceutical Co Ltd

-1.8%
Current
-0.2%
Average
7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1.8%
=
Net Income
-771.9m
/
Revenue
42.1B

Net Margin Across Competitors

Country CN
Market Cap 20.8B CNY
Net Margin
-2%
Country ZA
Market Cap 183.4B Zac
Net Margin
13%
Country CN
Market Cap 964.2B CNY
Net Margin
14%
Country ZA
Market Cap 130.7B Zac
Net Margin
9%
Country CN
Market Cap 859.8B CNY
Net Margin
28%
Country ZA
Market Cap 100.4B Zac
Net Margin
13%
Country HK
Market Cap 648B HKD
Net Margin
23%
Country IN
Market Cap 5.8T INR
Net Margin
5%
Country US
Market Cap 63.5B USD
Net Margin
22%
Country ZA
Market Cap 63.2B Zac
Net Margin
5%
Country US
Market Cap 60.9B USD
Net Margin
5%
No Stocks Found

Hubei Biocause Pharmaceutical Co Ltd
Glance View

Market Cap
20.8B CNY
Industry
Insurance

Hubei Biocause Pharmaceutical Co., Ltd. is an investment holding company that engages in the insurance industry. The company is headquartered in Jingmen, Hubei and currently employs 2,239 full-time employees. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The firm is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The firm distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

Intrinsic Value
4.46 CNY
Undervaluation 5%
Intrinsic Value
Price
H

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1.8%
=
Net Income
-771.9m
/
Revenue
42.1B
What is the Net Margin of Hubei Biocause Pharmaceutical Co Ltd?

Based on Hubei Biocause Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -1.8%.